hCAP-D2 Antibodies

Santa Cruz Biotechnology delivers a wide array of hCAP-D2 monoclonal antibodies for research in cell cycle regulation and chromosomal dynamics. hCAP-D2 Antibodies targeting hCAP-D2 are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). hCAP-D2, a crucial component of the condensin complex, plays a significant role in chromosome condensation and segregation during mitosis. Proper function of hCAP-D2 is essential for maintaining genomic stability, and its dysregulation has been implicated in various cancers. Research focused on hCAP-D2 can reveal important mechanisms in cellular processes and disease progression. Understanding the molecular interactions of hCAP-D2 provides insights into potential therapeutic approaches for cancer treatment. Investigating hCAP-D2's role in chromosome organization helps illuminate fundamental aspects of cell division and genome maintenance. Santa Cruz Biotechnology monoclonal antibodies targeting hCAP-D2 enable researchers worldwide to advance scientific understanding of cell cycle regulation and cancer biology.